Literature DB >> 7556649

Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis.

P Ben-Av1, L J Crofford, R L Wilder, T Hla.   

Abstract

Inflammatory mediators such as prostaglandin E2 (PGE2) and interleukin-1 (IL-1) induce angiogenesis by yet undefined mechanisms. We demonstrate that PGE2 and IL-1 induces the expression of vascular endothelial growth factor (VEGF), a selective angiogenic factor by rheumatoid synovial fibroblast cells. Transcripts for the EP1 and EP2 subtypes of PGE receptors are expressed in synovial fibroblasts. Activators of protein kinase A pathway stimulated the expression of VEGF whereas down-regulation of protein kinase C did not influence the PGE effect, suggesting that signalling from the EP2 receptor via the protein kinase A pathway is important. The induction of VEGF expression by PGE2 and interleukin-1 alpha may be an important mechanism in inflammatory angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556649     DOI: 10.1016/0014-5793(95)00956-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  99 in total

Review 1.  Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C.

Authors:  K Narko; B Enholm; T Mäkinen; A Ristimäki
Journal:  Int J Exp Pathol       Date:  1999-06       Impact factor: 1.925

Review 2.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

3.  National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms.

Authors:  Daniel H Hwang; Victor Fung; Andrew J Dannenberg
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

Review 4.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 5.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 6.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

7.  Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

Authors:  Neil D Gross; Jay O Boyle; Jason D Morrow; Myles K Williams; Chaya S Moskowitz; Kotha Subbaramaiah; Andrew J Dannenberg; Anna J Duffield-Lillico
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

8.  Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses.

Authors:  Rongqin Ren; Peter C Charles; Chunlian Zhang; Yaxu Wu; Hong Wang; Cam Patterson
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

9.  Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

Authors:  Sung-Hee Chang; Catherine H Liu; Rebecca Conway; David K Han; Kasem Nithipatikom; Ovidiu C Trifan; Timothy F Lane; Timothy Hla
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

10.  Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain.

Authors:  Xiao-Min Wang; Tian-Xia Wu; May Hamza; Edward S Ramsay; Sharon M Wahl; Raymond A Dionne
Journal:  Pain       Date:  2006-10-27       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.